United StatesOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 4,323 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 112,256 | 133,270 |
| Total Cites | 2,526 | 2,575 |
| H-index | 26 | 26 |
| Hm-index | 16 | 16 |
| Number of Single Authored Papers | 36 | 36 |
| Total Cites to Single Authored Papers | 624 | 624 |
| Number of Single+First Authored Papers | 56 | 56 |
| Total Cites to Single+First Authored Papers | 945 | 945 |
| Number of Single+First+Last Authored Papers | 81 | 81 |
| Total Cites to Single+First+Last Authored Papers | 1,940 | 1,946 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,278 | 2,323 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.11 |
| Self-Citation Percentage |
1.90%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 3,842 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 97,499 | 116,541 |
| Total Cites | 2,585 | 2,615 |
| H-index | 27 | 27 |
| Hm-index | 16 | 16 |
| Number of Single Authored Papers | 41 | 41 |
| Total Cites to Single Authored Papers | 615 | 616 |
| Number of Single+First Authored Papers | 63 | 63 |
| Total Cites to Single+First Authored Papers | 963 | 964 |
| Number of Single+First+Last Authored Papers | 96 | 96 |
| Total Cites to Single+First+Last Authored Papers | 2,171 | 2,179 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,353 | 2,381 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.10 |
| Self-Citation Percentage |
1.15%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 3,654 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 91,802 | 110,077 |
| Total Cites | 2,454 | 2,480 |
| H-index | 27 | 27 |
| Hm-index | 16 | 16 |
| Number of Single Authored Papers | 43 | 43 |
| Total Cites to Single Authored Papers | 582 | 583 |
| Number of Single+First Authored Papers | 66 | 66 |
| Total Cites to Single+First Authored Papers | 916 | 917 |
| Number of Single+First+Last Authored Papers | 100 | 100 |
| Total Cites to Single+First+Last Authored Papers | 2,048 | 2,056 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,236 | 2,260 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.10 |
| Self-Citation Percentage |
1.05%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 3,687 out of 271,773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 92,483 | 110,802 |
| Total Cites | 2,346 | 2,374 |
| H-index | 25 | 25 |
| Hm-index | 16 | 16 |
| Number of Single Authored Papers | 41 | 41 |
| Total Cites to Single Authored Papers | 559 | 560 |
| Number of Single+First Authored Papers | 63 | 63 |
| Total Cites to Single+First Authored Papers | 875 | 876 |
| Number of Single+First+Last Authored Papers | 96 | 96 |
| Total Cites to Single+First+Last Authored Papers | 1,962 | 1,970 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,142 | 2,168 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.10 |
| Self-Citation Percentage |
1.18%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.